Here, we demonstrate that blockade of PD‐L1 significantly improves tumor response to high but not low radiation doses in different tumor microenvironments by “shifting” the balance toward a more favorable anti‐tumorigenic phenotype. This evidence concerns the gene CD274 and neoplasm.